J Cancer Prev.  2016 Jun;21(2):104-109. 10.15430/JCP.2016.21.2.104.

Human Papillomavirus Prevalence and Type Distribution Among 968 Women in South Korea

• So KA
• Hong JH
• Lee JK

• KMID: 2353810
• DOI: http://doi.org/10.15430/JCP.2016.21.2.104

Abstract

BACKGROUND
Geographic variation in the prevalence of carcinogenic types and human papillomavirus (HPV) genotype distribution is closely associated with the impact of HPV prophylactic vaccines. We determined the prevalence and distribution of HPV genotypes among healthy women in Korea.
METHODS
This study included 968 healthy women who were examined at a health promotion center of the Korea University Guro Hospital between January and June 2013. Each participant had a Pap test and a HPV DNA test using the Anyplexâ„¢ II HPV 28 Detection system, which detects 19 high-risk HPVs (HR HPVs) and 9 low-risk HPVs (LR HPVs). Women with abnormal cytology and/or positivity for HR HPVs were referred to colposcopic biopsy.
RESULTS
Overall HR HPV prevalence based on the assay was 33.7%. Among them, 225 women had single infection and 101 women had multiple infection. The most frequently occurring HR HPV types were 53 (6.5%), 52 (6.1%), 58 (4.8%), 16 (4.5%), and 68 (4.2%). The most frequently occurring LR HPV types were 54 (5.4%), 70 (3.8%), 42 (3.6%), 61 (3.4%), and 44 (3.1%). The prevalence of HPV 16 was highest (17.6%) among women with cervical intraepithelial neoplasia (CIN) and HPV 16 was strongly associated with a diagnosis of CIN2/3 (odds ratio = 20.5; 95% confidence interval: 3.9-107.1; P < 0.0001).
CONCLUSIONS
HPV 53, 52, 58, 16, and 68 were common HR HPV types among healthy Korean women. HPV16 was the most common type in high-grade CIN lesions, as shown in most studies worldwide. The results might be useful information for cervical cancer prevention in South Korea.

Keyword

Human papillomavirus; Cervical intraepithelial neoplasia; Cytology

MeSH Terms

Biopsy
Cervical Intraepithelial Neoplasia
Diagnosis
Female
Genotype
Health Promotion
Human papillomavirus 16
Human Papillomavirus DNA Tests
Humans*
Korea*
Papanicolaou Test
Prevalence*
Uterine Cervical Neoplasms
Vaccines
Vaccines